CBT
PMC

Central Bank & Trust’s PharMerica Corporation PMC Stock Holding History

Central Bank & Trust’s Portfolio PMC Stock Details PMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-380
Closed -$9K – 349
2016
Q2 		$9K Hold
380
– – ﹤0.01% 267
2016
Q1 		$8K Hold
380
– – ﹤0.01% 285
2015
Q4 		$13K Hold
380
– – ﹤0.01% 270
2015
Q3 		$11K Buy
380
+162
+74% +$5.44K ﹤0.01% 299
2015
Q2 		$7K Hold
218
– – ﹤0.01% 306
2015
Q1 		$6K Buy
+218
New +$5.42K ﹤0.01% 288

Other funds holding PMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Central Bank & Trust's PMC Position: Q3 2016 in Review

Central Bank & Trust sold out of PharMerica Corporation (PMC) in Q3 2016, closing a stake of 380 shares — an estimated $9K sold.

Central Bank & Trust first reported a position in PMC in Q1 2015 and held it in 6 quarters. The position peaked at $13K in Q4 2015. 172 funds tracked by Wall St. Rank hold PMC as of Q3 2016.

  • Central Bank & Trust reported no remaining PharMerica Corporation position as of Q3 2016 after selling out during the quarter.
  • Central Bank & Trust sold 380 PharMerica Corporation shares in Q3 2016, an estimated $9K.
  • Central Bank & Trust first reported a position in PharMerica Corporation in Q1 2015 and held it in 6 quarters.
  • Central Bank & Trust's PharMerica Corporation position peaked at $13K in Q4 2015.
  • 172 funds tracked by Wall St. Rank held PharMerica Corporation as of Q3 2016.

Based on Central Bank & Trust's 13F filing for Q3 2016, filed 7 Oct 2016.